Screening and Monitoring ILD in Rheumatic Diseases

This chapter discusses the guidelines for monitoring and screening patients with interstitial lung disease (ILD) in rheumatic diseases. It provides recommendations for screening tests and monitoring frequency based on specific diseases, emphasizing the importance of collaborative management between rheumatologists and pulmonologists. The chapter also covers the treatment options for ILD, considering factors like cost, access, and toxicity.